DiNAQOR, a gene therapy platform company, announced that Hans Rudolf Trüeb (pictured) has been appointed general counsel and corporate secretary. The company also announced the addition of Mauro Giacca to DiNAQOR’s Scientific Advisory Board (SAB), and the appointments of John McLaren as Chairman of DiNAQOR’s UK subsidiary and Eduard Ayuso as Chief Technology Officer.
Hans Rudolf Trüeb, DiNAQOR’s General Counsel and Corporate Secretary, is a senior partner at Walder Wyss. He advises Swiss and international clients in corporate and technology-related transactions as well as governance and compliance issues. Mr. Trüeb is also an adjunct professor at Zurich University Law School. He earned his legal degrees at the University of Zurich and the University of California, Berkeley. Furthermore, he is Co-Chair of the Zurich Bar’s Technology and Telecom Law Practice Group.
“DiNAQOR is growing rapidly and we are thrilled to appoint these four distinguished leaders to advance our mission to bring gene therapy to the failing heart,” said Johannes Holzmeister, Co-Founder, Chairman and CEO at DiNAQOR.